Get the App

Back Stocks profile

Stock analysis tool for investors

Amrutanjan Health Care Ltd.

NSE: AMRUTANJAN | BSE:590006

₹775.75 -7.80 (-1.00%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

770.10

Today’s High

804.00

52W low

563.90

52W High

804.00

Open Price

793.00

Prev. Close

601.7500

Volume

768480.00

Value

596148360.00

Fundamentals

Market Cap Cr

2242.70

Price to Earnings

51.00

Price to Book Value

7.70

Dividend Yield

0.60

PE to Growth

9.90

Op Revenue TTM Cr

394.49

Net Profit TTM Cr

44.01

Cash From Operating Activity Cr

20.18

Return on Equity %

13.69

EMA & SMA

Bullish Moving Averages

16

Bearish Moving Averages

0

5Day EMA

740.1

10Day EMA

713.2

12Day EMA

706.1

20Day EMA

687

26Day EMA

678

50Day EMA

657.4

100Day EMA

639.7

200Day EMA

635.4

5Day SMA

729.8

10Day SMA

701

20Day SMA

678.7

30Day SMA

657.4

50Day SMA

654

100Day SMA

626.2

150Day SMA

619.2

200Day SMA

624.3

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

02 May, 2024

31.3

Week

37.8

Month

44.1

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

783.28

PIVOT

First Resistance

796.47

Second Resistance

817.18

Third Resistance

830.37

First Support

762.57

Second Support

749.38

Third Support

728.67

Relative Strength Index

73.84

Money Flow Index

89.82

MACD

28.14

MACD Signal

16.76

Average True Range

27.94

Average Directional Index

33.55

Rate of Change (21)

24.62

Rate of Change (125)

30.05

Commodity Channel Index

270.6

Williams %R

-16.5

BETA

1 Month

2.55

3 Month

0.91

1 Year

0.32

3 Year

0.14

PRICE CHANGE ANALYSIS

↑ 12.51%

1 Week

Low

High

680.2

804

↑ 22.45%

1 Month

Low

High

625.95

804

↑ 35.23%

3 Months

Low

High

570.6

804

↑ 29.02%

6 Months

Low

High

570

804

↑ 28.14%

1 Year

Low

High

563.9

804

Indicator Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Jun 2021 Graph
Total Qtr Revenue cr 120.76 103.26 81.55 105.14 101.32 113.75 73.97 111.71 113.89 114.67 80.95
Operating Expenses Qtr 95.42 92.47 70.70 87.34 85.49 94.79 67.62 90.20 85.07 87.44 63.66
Operating Profit Qtr 21.57 6.84 7.16 12.98 12.16 15.93 3.33 16.35 25.62 22.94 14.55
EBIDT Qtr Cr 25.34 10.79 10.85 17.80 15.83 18.96 6.34 21.51 28.82 27.23 17.29
Depreciation Qtr 1.58 1.55 1.39 1.31 1.31 1.52 1.07 1.19 0.88 0.80 0.92
Net Profit Qtr 17.45 6.85 7.01 12.70 10.71 12.77 3.66 14.71 20.58 19.85 12.06
Basic EPS Qtr 6.05 2.36 2.40 4.35 3.67 4.37 1.25 5.09 7.05 6.79 4.12
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total Revenue Annual 394.18 421.22 344.16 269.80 260.36
Operating Expenses Annual Cr 335.24 326.37 258.09 230.76 221.95
Operating Profit Annual 44.39 79.47 74.75 30.71 31.28
Operating Profit Margin Annual % 11.26 18.87 21.72 11.38 12.01
Total Expenses Annual Cr 340.53 330.65 262.26 235.34 225.19
EBIDT Annual Cr 58.93 94.86 86.07 39.03 38.41
EBIDT Annual margin % 14.95 22.52 25.01 14.47 14.75
Depreciation 5.21 3.80 3.67 4.36 3.16
PAT Before ExtraOrdinary Items Annual Cr 39.83 67.19 61.19 25.08 25.00
Net Profit Annual 39.83 67.19 61.19 25.08 24.51
Basic EPS Annual 13.65 23.00 20.94 8.58 8.38
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total ShareHolders Funds Annual 290.77 265.12 215.56 159.43 145.74
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 8.31 7.27 6.60 6.86 5.76
Total Current Liabilities Annual Cr 63.01 77.47 52.10 39.06 36.12
Total Capital Plus Liabilities Annual Cr 362.09 349.87 274.27 205.35 187.61
Fixed Assets Annual 50.03 45.79 24.83 26.10 25.70
Total Non Current Assets Annual 102.55 75.22 51.37 79.52 48.00
Total Current Assets Annual 259.54 274.65 222.90 125.82 139.62
Total Assets Annual 362.09 349.87 274.27 205.35 187.61
Contingent Liabilities plus Commitments Annual Cr 10.12 11.39 12.94 12.84 11.98
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Cash from Operating Activity Annual 20.18 52.20 89.76 18.18 21.17
Cash from Investing Activity Annual -2.48 -36.21 -87.76 -13.85 -11.01
Cash from Financing Annual Activity -14.99 -16.70 -6.32 -11.69 -6.95
Net Cash Flow Annual 2.72 -0.72 -4.31 -7.36 3.20
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Book Value Per Share Annual 99.47 90.70 73.75 54.54 49.86
ROE Annual % 13.69 25.34 28.38 15.73 16.82
ROCE Annual % 17.96 33.42 37.09 20.85 23.26
Total Debt to Total Equity Annual 0.00 0.00 0.00 0.00 0.00
EBDIT Annual Margin % 15.52 23.37 25.86 14.92 15.16
Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr
Operating Profit Qtr
EBIDT Qtr Cr
Depreciation Qtr
Net Profit Qtr
Basic EPS Qtr
Indicator Mar 2017 Mar 2016 Mar 2015 Mar 2014 Mar 2013 Graph
Total Revenue Annual 228.81 192.42 171.04 144.67 141.92
Operating Expenses Annual Cr 194.96 155.96 142.80 119.92 120.24
Operating Profit Annual 29.02 30.79 23.76 21.81 17.41
Operating Profit Margin Annual % 12.68 16.00 13.89 15.07 12.27
Total Expenses Annual Cr 198.26 159.74 146.73 125.29 126.44
EBIDT Annual Cr 33.85 36.47 28.24 24.75 21.68
EBIDT Annual margin % 14.79 18.95 16.51 17.11 15.28
Depreciation 2.87 3.35 3.21 3.60 3.73
PAT Before ExtraOrdinary Items Annual Cr 21.14 20.58 15.07 12.44 10.12
Net Profit Annual 21.14 20.58 15.07 12.44 10.12
Basic EPS Annual 14.47 14.08 10.31 8.51 6.92
Indicator Mar 2017 Mar 2016 Mar 2015 Mar 2014 Mar 2013 Graph
Total ShareHolders Funds Annual 126.01 108.74 94.95 89.24 82.27
Minority Interest Liability Annual Cr 0.00 0.00 0.00 0.00 0.00
Total Non Current Liabilities Annual Cr 3.73 3.72 3.10 3.78 3.90
Total Current Liabilities Annual Cr 32.02 27.98 25.85 27.25 37.99
Total Capital Plus Liabilities Annual Cr 161.76 140.44 123.90 120.27 124.16
Fixed Assets Annual 30.88 29.63 27.86 27.73 30.63
Total Non Current Assets Annual 50.99 39.95 41.06 42.02 60.78
Total Current Assets Annual 110.77 100.49 82.84 78.25 63.38
Total Assets Annual 161.76 140.44 123.90 120.27 124.16
Contingent Liabilities plus Commitments Annual Cr 29.36 29.36 24.65 22.24 16.44
Indicator Mar 2017 Mar 2016 Mar 2015 Mar 2014 Mar 2013 Graph
Cash from Operating Activity Annual 0.00 20.70 18.32 17.45 8.71
Cash from Investing Activity Annual 0.00 4.16 -4.89 16.49 5.22
Cash from Financing Annual Activity 0.00 -13.10 -11.93 -13.92 -14.26
Net Cash Flow Annual - 11.76 1.49 20.02 -0.33
Indicator Mar 2017 Mar 2016 Mar 2015 Mar 2014 Mar 2013 Graph
Book Value Per Share Annual 86.22 74.40 64.97 61.06 56.29
ROE Annual % 16.77 18.92 15.87 13.94 12.29
ROCE Annual % 23.87 29.45 25.52 22.73 20.83
Total Debt to Total Equity Annual 0.02 0.02 0.03 0.09 0.18
EBDIT Annual Margin % 15.11 19.52 16.95 17.46 15.75
Name Holding Percent Holding Id Pledged % Locked %
SUNDARAM MUTUAL FUND A/C SUNDARAM SMALL CAP FUND 1.68 75044938 - -
DIPAK KANAYALAL SHAH 1.06 75044951 - -
Name Holding Percent Holding Id Pledged % Locked %
SAMBHU PRASAD SIVALENKA 3.6 75044925 0 0
RAMAA P ARIKIREVULA 3.02 75044926 0 0
AMULYA KAMAKSHI PRIYA ARIKIREVULA 2.13 75044927 0 0
GOODHEALTH HOLDINGS PRIVATE LIMITED 20.15 75044931 0 0
SAMBHUPRASAD SIVALENKA 10.34 75044932 0 0
SATHYANARAYANA MURTHI PASUMARTHI 8.68 75044933 0 0
RAMALINGAM GANTI 2.53 75044934 0 0
Name Holding Percent Holding Id
DSP SMALL CAP FUND 5.07 75044937
SUNDARAM MUTUAL FUND A/C SUNDARAM SMALL CAP FUND 1.68 75044938
Name Holding Percent Holding Id
RAJASHEKAR IYER 1.66 75044950
DIPAK KANAYALAL SHAH 1.06 75044951
HUF 0.89 75044944
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Feb 20, 2024 1 INTERIM Feb 20, 2024 Equity Share
Nov 23, 2023 1 INTERIM Nov 23, 2023 Equity Share
Sep 14, 2023 2.6 FINAL Sep 14, 2023 Equity Share
Feb 24, 2023 1 INTERIM Feb 24, 2023 Equity Share
Nov 14, 2022 1 INTERIM Nov 15, 2022 Equity Share
Sep 14, 2022 2.6 FINAL - Equity Share
Feb 18, 2022 1 INTERIM Feb 21, 2022 Equity Share
Nov 16, 2021 1 INTERIM Nov 17, 2021 Equity Share
Sep 15, 2021 2.6 FINAL Sep 16, 2021 Equity Share
Feb 17, 2021 0.8 INTERIM Feb 19, 2021 Equity Share
Nov 19, 2020 0.8 INTERIM Nov 20, 2020 Equity Share
Feb 18, 2020 1.55 INTERIM Feb 21, 2020 Equity Share
Nov 15, 2019 0.55 INTERIM Nov 18, 2019 Equity Share
Sep 17, 2019 1.05 FINAL - Equity Share
Feb 20, 2019 0.55 INTERIM Feb 21, 2019 Equity Share
Nov 12, 2018 0.55 INTERIM Nov 13, 2018 Equity Share
Sep 07, 2018 0.85 FINAL - Equity Share
Feb 22, 2018 1.1 INTERIM Feb 23, 2018 Equity Share
Nov 16, 2017 1.1 INTERIM Nov 17, 2017 Equity Share
Sep 13, 2017 1.65 FINAL Sep 14, 2017 Equity Share
Feb 16, 2017 1.1 INTERIM Feb 17, 2017 Equity Share
Nov 17, 2016 1.1 INTERIM Nov 18, 2016 Equity Share
Mar 18, 2016 2.65 INTERIM Mar 21, 2016 Equity Share
Feb 17, 2016 1.2 INTERIM Feb 19, 2016 Equity Share
Sep 10, 2015 2.4 FINAL - Equity Share
Feb 13, 2015 1.1 INTERIM Feb 17, 2015 Equity Share
Sep 17, 2014 2.2 FINAL - Equity Share
Feb 17, 2014 1 INTERIM Feb 19, 2014 Equity Share
Aug 02, 2013 2 FINAL - Equity Share
Feb 21, 2013 1 INTERIM Feb 22, 2013 Equity Share
Sep 20, 2012 10 FINAL - Equity Share
Feb 23, 2012 5 INTERIM Feb 24, 2012 Equity Share
Sep 12, 2011 10 FINAL - Equity Share
Feb 21, 2011 5 INTERIM Feb 22, 2011 Equity Share
Aug 13, 2010 10 FINAL - Equity Share
Feb 09, 2010 5 INTERIM Feb 10, 2010 Equity Share
Sep 16, 2009 12 FINAL - Equity Share
Feb 04, 2009 5 INTERIM Feb 05, 2009 Equity Share
Sep 08, 2008 3 FINAL - Equity Share
Jul 28, 2008 40 INTERIM Jul 29, 2008 Equity Share
Feb 05, 2008 4 INTERIM Feb 06, 2008 Equity Share
Aug 03, 2007 2 FINAL - Equity Share
Jan 24, 2007 4 INTERIM Jan 25, 2007 Equity Share
Jul 03, 2006 2.7 FINAL - Equity Share
Feb 14, 2006 1.3 INTERIM Feb 15, 2006 Equity Share
Jul 29, 2005 2.2 FINAL - Equity Share
Feb 14, 2005 1.3 INTERIM Feb 15, 2005 Equity Share
Aug 11, 2004 2 FINAL - Equity Share
Feb 16, 2004 1.3 INTERIM Feb 18, 2004 Equity Share
Sep 15, 2003 1.7 FINAL - Equity Share
Feb 21, 2003 1.3 INTERIM Feb 25, 2003 Equity Share
Ex-Date Split Ratio Record Date
Apr 13, 2018 2:1 2018-04-16
Oct 25, 2012 10:2 2012-10-29
Ex-Date Purpose Notes
Feb 09, 2024 Quarterly Results & Interim Dividend -
Nov 10, 2023 Quarterly Results & Interim Dividend -
Aug 02, 2023 Quarterly Results -
Jun 30, 2023 Buy Back of Shares -
May 30, 2023 Audited Results & Final Dividend (Revised)
Feb 14, 2023 Quarterly Results & Interim Dividend -
Nov 04, 2022 Quarterly Results & Interim Dividend -
Aug 12, 2022 Quarterly Results -
May 24, 2022 Audited Results & Final Dividend -
Feb 11, 2022 Quarterly Results & Interim Dividend -
Nov 09, 2021 Quarterly Results & Interim Dividend -
Aug 14, 2021 Quarterly Results -
Jun 29, 2021 Others Inter alia, to consider and approve Appointment of Additional Director (Non Executive Independent Catogery)
May 27, 2021 Audited Results & Final Dividend -
Feb 11, 2021 Quarterly Results & Interim Dividend -
Nov 12, 2020 Quarterly Results & Interim Dividend -
Aug 13, 2020 Quarterly Results & ESOP -
Jun 18, 2020 Audited Results -
Feb 12, 2020 Quarterly Results & Interim Dividend -
Nov 07, 2019 Quarterly Results & 1st Interim Dividend -
Aug 13, 2019 Quarterly Results -
May 23, 2019 Audited Results & Final Dividend -
Feb 12, 2019 Quarterly Results & 2nd Interim Dividend -
Nov 01, 2018 Quarterly Results & Interim Dividend -
Aug 09, 2018 Quarterly Results -
May 24, 2018 Audited Results & Final Dividend -
Feb 13, 2018 Qtr Results, Int. Dividend & Stock Split -
Nov 09, 2017 Quarterly Results & 1st Interim Dividend -
Aug 14, 2017 Quarterly Results & Others Fix record date for the payment of dividend subject to the approval of the shareholders.
May 16, 2017 Audited Results & Final Dividend -
Feb 09, 2017 Quarterly Results & Interim Dividend -
Nov 10, 2016 Quarterly Results & 1st Interim Dividend -
Aug 11, 2016 Quarterly Results & Others Merger of the Wholly-owned Subsidiary, M/s. Amrutanjan Pharmaessence Private Limited with M/s. Amrutanjan Health Care Limited.
May 06, 2016 Audited Results -
Mar 11, 2016 Second Interim Dividend -
Feb 11, 2016 Quarterly Results & Interim Dividend -
Nov 05, 2015 Quarterly Results -
Aug 13, 2015 Quarterly Results Appointment of Mr. M. Srinivasan as COMPANY SECRETARY with effect from July 27, 2015.
May 15, 2015 Audited Results & Final Dividend -
Feb 05, 2015 Quarterly Results & Interim Dividend -
Oct 27, 2014 Quarterly Results -
Aug 12, 2014 Quarterly Results -
May 30, 2014 Audited Results & Final Dividend -
Feb 07, 2014 Quarterly Results & Interim Dividend -
Nov 14, 2013 Quarterly Results -
Aug 07, 2013 Quarterly Results -
May 30, 2013 Audited Results & Dividend -
Feb 11, 2013 Quarterly Results & Interim Dividend -
Nov 09, 2012 Quarterly Results (Revised)
Aug 06, 2012 Quarterly Results -
May 30, 2012 Audited Results -
Feb 13, 2012 Qtrly Results,Interim Dividend & Merger The Board has approved the Merger of Wholly Owned Subsidiary M/s. Siva's Soft Drinks Pvt. Ltd with the Company.
Nov 04, 2011 Quarterly Results -
Aug 08, 2011 Quarterly Results & Final Dividend To consider and take on record, the Unaudited Financial Results of the Company for the 1st quarter ended June 30, 2011 and to consider and declare Final Dividend for the financial year 2010-11.
May 03, 2011 Quarterly Results & Buy Back of Shares To approve the proposal for buy-back of Equity Shares of the Company Under Section 77A of the Companies Act, 1956 and SEBI (Buy-back of Securities) Regulations, 1998.
Feb 10, 2011 Interim Dividend -
Jan 19, 2011 To consider new business proposals Inter alia, to consider new business proposals.
Nov 13, 2010 Quarterly Results -
Aug 09, 2010 Quarterly Results -
Jul 14, 2010 Audited Results, Dividend & Buyback The Board has resolved to withdraw the buy-back offer of Equity Shares of the Company in view of the fact that the market prices of the Shares have gone up over & Incorporated 2 WoS Co's.
May 13, 2010 Quarterly Results -
Jan 30, 2010 Qtrly Results, Intm. Dividend & Buy Back For Buy-Back of Equity Shares U/S 77A, 77AA and 77B of the Co's Act, 1956 through open market route (stock exchange route), pursuant to Regulation 14(2)(a) of SEBI (BBSs) Regulations, 1998.
Oct 23, 2009 Quarterly Results -
Jul 27, 2009 Quarterly Results -
Jun 26, 2009 Audited Results & Final Dividend -
Jun 25, 2009 Appointment/Resignation of Director's To appoint Mr. A Satish Kumar as an Additional Director, He shall act as a Non-Executive and Independent Director of the Co. & to accept the resignation of Mr. N V Nelliappan from the Directorship.
Jan 30, 2009 Quarterly Results & Interim Dividend -
Oct 30, 2008 Quarterly Results -
Oct 11, 2008 Buy Back of Shares To consider Buy-back its equity shares under Section 77A, 77AA and 77B of the Companies Act, 1956 through open market route pursuant to Regulation 14(2)(a) of SEBI Regulations, 1998.
Jul 17, 2008 Quarterly Results & Interim Dividend To consider declaration of "Special One Time Interim Dividend - 2008-09" to the shareholders of the Company from the realized capital profits made through sale of land and buildings.
Jun 30, 2008 Audited Results & Final Dividend -
Jan 31, 2008 Quarterly Results & Interim Dividend -
Oct 26, 2007 Quarterly Results -
Jul 20, 2007 Quarterly Results -
Jun 25, 2007 Audited Results & Final Dividend -
Jan 19, 2007 Quarterly Results & Interim Dividend -
Oct 14, 2006 Quarterly Results -
Jul 24, 2006 Quarterly Results -
May 29, 2006 Accounts & Dividend -
Jan 30, 2006 Quarterly Results & Interim Dividend -
Oct 28, 2005 Quarterly Results -
Jul 29, 2005 Quarterly Results -
Jun 24, 2005 Accounts & Dividend -
Jan 31, 2005 Quarterly Results -
Jul 30, 2004 Quarterly Results -
Jun 30, 2004 Dividend & Accounts -
Jan 31, 2004 Quarterly Results & Interim Dividend -
Nov 01, 2003 Quarterly Results -
Aug 25, 2003 Dividend & Accounts -
Jul 31, 2003 Quarterly Results -
May 05, 2003 Quarterly Results -
Jan 31, 2003 Interim Dividend -
Nov 01, 2002 Quarterly Results -
Aug 24, 2002 Accounts & Quarterly Results & Dividend -
May 31, 1997 Half Yearly Results -
Ex-Date Bonus Ratio Record Date
Oct 29, 2001 1:1 2001-11-16
Bigul
03 May 2024

AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of Loss of Share Certificate
Bigul
02 May 2024

AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation for issue of Duplicate Share Certificate/ Letter of confirmation
Bigul
01 May 2024

AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Announcement Under Regulation 30 (LODR) - Capital Expenditure Proposal Approved By The Board

 Capital Expenditure proposal approved by the Board
Bigul
26 Apr 2024

AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Certificate U/R 40(9) Of SEBI (LODR) Regulations, 2015

 Certificate received from M/s. SPNP and Associates u/r 40(9) of SEBI (LODR) Regulations, 2015
Bigul
26 Apr 2024

AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Certificate U/R 40(9) Of SEBI (LODR) Regulations, 2015

 Certificate received from M/s. SPNP and Associates u/r 40(9) of SEBI (LODR) Regulations, 2015
Bigul
25 Apr 2024

AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyAMRUTANJAN HEALTH CARE LTD.- 2CIN NO.L24231TN1936PLC000017 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: M SRINIVASAN Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: [email protected] Name of the Chief Financial Officer: N SWAMINATHAN Designation: CHIEF FINANCIAL OFFICER EmailId: [email protected] Date: 25/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Bigul
08 Apr 2024

AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Compliance Certificate For The Period Ended March 31, 2024

 Pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith the ''Compliance Certificate'' duly signed by the Compliance officer and authorized representative of the share transfer agent.
Bigul
08 Apr 2024

AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018
Bigul
26 Mar 2024

AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Closure of Trading Window

 Intimation of Closure of Trading Window for the quarter and year ending 31st March, 2024
Bigul
12 Mar 2024

AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of Loss of Share Certificate
See all News

FAQs

The latest market price of Amrutanjan Health Care Ltd. on NSE was Rs. 775.75 as of today.

The opening share price of Amrutanjan Health Care Ltd. was Rs. 793.00 as of today.

The 52-week high share price of Amrutanjan Health Care Ltd. was Rs. 804.00.

The 52 week low share price of Amrutanjan Health Care Ltd. was Rs. 563.90.

Amrutanjan Health Care Ltd. has a market cap of Rs. 2242.70 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Amrutanjan Health Care Ltd. is 9.90. Please refer to the Fundamentals section for further details.

The operating revenue for Amrutanjan Health Care Ltd. in the last FY was Rs.  394.49 crore. Please refer to the Financials section for further details.

The Net Profit for Amrutanjan Health Care Ltd. in the last FY was Rs. 44.01 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Amrutanjan Health Care Ltd. was on 2024-02-20 for Rs. 1 per share. According to today’s share price, the dividend yield of Amrutanjan Health Care Ltd. stands at 0.60. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Amrutanjan Health Care Ltd. was as of 2001-10-29. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Amrutanjan Health Care Ltd. was as of 2012-10-25. The split ratio declared in this issue was 10:2. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Amrutanjan Health Care Ltd..

Close

Let's Open Free Demat Account